Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
4-6 minutes (native TRH); analog taltirelin has extended duration
Delivery
Subcutaneous or intravenous injection; oral administration for stable analogs like taltirelin
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Thyrotropin-Releasing Hormone (TRH) is a tripeptide hormone naturally produced in the hypothalamus that regulates thyroid function by stimulating the release of thyroid-stimulating hormone (TSH) from the pituitary gland. Beyond its endocrine role, TRH exhibits neuroprotective properties and influences energy metabolism, neural oscillations, and cognitive function. Research has demonstrated its potential therapeutic applications in neurodegenerative conditions, PTSD-like symptoms, and metabolic regulation.
TRH analogs such as taltirelin are used in research settings, typically administered at doses ranging from 0.5-2 mg orally or via injection. Research protocols vary based on application, with some studies examining single-dose effects while others investigate chronic administration. Timing is often coordinated with circadian rhythms due to TRH's role in hypothalamic-pituitary axis regulation.
TRH binds to TRH receptors (TRHR1 and TRHR2) in the pituitary gland, triggering TSH release which subsequently stimulates thyroid hormone production. In the central nervous system, TRH activates the phosphatidylinositol 3-kinase/AKT pathway, promoting neuroprotection and new protein synthesis. TRH neurons in the paraventricular nucleus regulate branched-chain amino acid catabolism, influencing energy expenditure. The peptide also modulates neural oscillations and protects against glutamate excitotoxicity in hippocampal neurons.
Thyrotropin-Releasing Hormone (TRH) is a tripeptide hormone naturally produced in the hypothalamus that regulates thyroid function by stimulating the release of thyroid-stimulating hormone (TSH) from the pituitary gland. Beyond its endocrine role, TRH exhibits neuroprotective properties and influences energy metabolism, neural oscillations, and cognitive function. Research has demonstrated its potential therapeutic applications in neurodegenerative conditions, PTSD-like symptoms, and metabolic regulation.
Thyrotropin-Releasing Hormone (TRH) has an approximate half-life of 4-6 minutes (native TRH); analog taltirelin has extended duration. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Thyrotropin-Releasing Hormone (TRH) is typically delivered via subcutaneous or intravenous injection; oral administration for stable analogs like taltirelin. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
TRH binds to TRH receptors (TRHR1 and TRHR2) in the pituitary gland, triggering TSH release which subsequently stimulates thyroid hormone production. In the central nervous system, TRH activates the phosphatidylinositol 3-kinase/AKT pathway, promoting neuroprotection and new protein synthesis. TRH neurons in the paraventricular nucleus regulate branched-chain amino acid catabolism, influencing energy expenditure. The peptide also modulates neural oscillations and protects against glutamate excitotoxicity in hippocampal neurons.
Studied benefits of Thyrotropin-Releasing Hormone (TRH) include: Neuroprotection against glutamate toxicity and excitotoxic damage, Alleviation of PTSD-like symptoms and restoration of neural oscillations, Regulation of thyroid axis and metabolic function, Enhancement of energy expenditure through metabolic pathway modulation, Potential therapeutic benefit in hypothalamic dysfunction conditions, Maintained gene expression during neural regeneration processes, Protection of hippocampal neurons through AKT pathway activation. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Thyrotropin-Releasing Hormone (TRH) include: Transient increases in blood pressure, Nausea or gastrointestinal discomfort, Headache, Anxiety or nervousness at higher doses, Altered thyroid hormone levels with chronic use, Potential pituitary desensitization with prolonged administration. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other cognitive compounds in the Peptides Calculator library.
Half-life · Estimated 30-60 minutes (typical for short peptides)
Half-life · Unknown; estimated at 20-30 minutes in circulation
Half-life · 6-8 hours
Half-life · Approximately 30-60 minutes with C-terminal amidation providing enhanced stability
Half-life · 60-90 minutes
Half-life · Approximately 2-4 hours